F 0604
Ensure that each resident is free from the use of physical restraints, unless needed for medical treatment.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, record review and staff interview the facility failed to ensure residents with reclining
wheelchairs were assessed for possible restraint use. This affected two (Resident #12 and #34) of two
residents reviewed for possible restraint use.
Residents Affected - Few
Findings include:
1. Review of the medical record for Resident #12 revealed an admission date of 01/05/21 with diagnoses
that included end stage renal disease with hemodialysis, diabetes mellitus and atrial fibrillation.
Review of the physician's orders for Resident #12 revealed on 10/17/24 that while resident is up in
tilt-in-space wheel chair (wheelchair which can recline for comfort and positioning) to tilt resident back to
30-40 degrees every hour for 5-20 minutes as tolerates to relieve pressure off coccyx and sacrum. No
evidence was found in the medical record to determine when the tilt-in-space wheelchair was initiated and
no evidence of an assessment to determine if the tilt and space wheelchair was a restraint.
Observation of Resident #12 on 06/23/25 at 10:44 A.M. revealed the resident was reclined in a tilt-in-space
wheelchair.
Interview with the Director of Nursing on 06/23/25 at 3:55 P.M. verified Resident #12 was not assessed for
potential use of a restraint with the tilt-in-space wheelchair. The Director of Nursing further indicated the
resident had utilized the tilt-in-space wheelchair for a prolonged period.
2. Review of the medical record for Resident #34 revealed an admission date of 04/15/23 with diagnoses
that included Alzheimer's disease with dementia, diabetes mellitus and post-traumatic stress disorder.
Review of the physician's orders for Resident #34 revealed on 10/17/24 that while resident is up in
tilt-in-space wheel chair, to tilt the resident back to 30-40 degrees every hour for 5-20 minutes as tolerates
to relieve pressure off coccyx and sacrum. No evidence was found to determine when the tilt-in-space
wheelchair use was initiated.
Further review of the medical record revealed no assessment was completed to determine if the use of the
tilt-in-space wheelchair was a potential treatment.
Observation of Resident #34 on 06/23/25 at 1:29 P.M. revealed the resident was reclined in a
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
365496
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365496
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/26/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arbors at Woodsfield
37930 Airport Road
Woodsfield, OH 43793
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
tilt-in-space wheelchair. Additional observation on 06/23/25 at 3:01 P.M. revealed the resident was reclined
in a tilt-in-space wheelchair.
Interview with the Director of Nursing on 06/23/25 at 3:55 P.M. verified Resident #34 had not been
assessed to determine if the use of a tilt-in-space wheelchair was a potential restraint prior to 06/23/25.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365496
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365496
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/26/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arbors at Woodsfield
37930 Airport Road
Woodsfield, OH 43793
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
Ensure each resident receives an accurate assessment.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review and interview the facility failed to ensure comprehensive assessments were accurate. This
affected two residents (Resident #9 and #48) of 12 residents reviewed for accurate assessment.
Residents Affected - Few
Findings include:
1. Review of Resident #9's medical record revealed an admission date of 08/26/13 with diagnoses including
cerebral palsy, major depressive disorder, generalized anxiety disorder, allergic rhinitis, excoriation (skin
picking) disorder, irritant contact dermatitis, and candidiasis of the skin.
Review of the physician orders revealed to administer hydroxyzine (Vistaril, an anti-histamine medication
that is sometimes prescribed to treat anxiety) 50 milligrams (mg) by mouth every eight hours as needed for
itching for 90 days written 04/24/25.
Further review of the electronic medical record (EMR) revealed no evidence of the resident having received
an anti-anxiety medication from 05/01/25 through 05/06/25.
Review of the annual Minimum Data Set (MDS) dated [DATE] revealed the MDS reflected the resident had
received an anti-anxiety medication during the seven day MDS review period (05/01/25 through 05/07/25).
On 06/24/25 at 3:32 P.M., an interview with Corporate Nurse #100 confirmed the resident's annual MDS
was not accurately coded to reflect the medications the resident received. She acknowledged the resident
was marked on the MDS as having received an anti-anxiety medication when the resident was not
receiving one. The Corporate Nurse verified Vistaril was an antihistamine and not an antianxiety medication
and should not have been coded as such.
2. Review of Resident #48's medical record revealed an admission date of 04/18/25 with diagnoses
including unspecified dementia with psychotic disturbances, post-traumatic stress disorder, type II diabetes,
chronic kidney disease- stage III, atrial fibrillation, peripheral vascular disease and generalized anxiety
disorder.
Review of the physician orders revealed to administer rosuvastatin calcium oral tablet 40 milligrams by
mouth at bedtime for hyperlipidemia.
Review of the admission MDS dated [DATE] revealed the resident was cognitively intact. The resident's
diagnoses (under Section I) did not include the diagnosis of hyperlipidemia despite the resident receiving
rosuvastatin calcium every night at bedtime since admission to the facility.
On 06/24/25 at 10:05 A.M. interview with the Director of Nursing and Corporate Nurse #100 verified that the
resident's admission MDS completed on 04/25/25 was not coded accurately to reflect the resident's
diagnosis of hyperlipidemia. Both acknowledged the resident had been receiving rosuvastatin at bedtime for
hyperlipidemia since admission to the facility.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365496
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365496
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/26/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arbors at Woodsfield
37930 Airport Road
Woodsfield, OH 43793
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
Based on record review and interview the facility failed to ensure residents had appropriate indication for
use of medications and did not have duplicate medication therapy without appropriate justification. This
affected one (Resident #46) of five residents reviewed for medication use.
Residents Affected - Few
Findings include:
Review of Resident #46's medical record revealed an admission date of 01/23/25 with diagnoses that
included traumatic brain injury and post-traumatic hydrocephalus. No evidence of any gastro-esophageal
reflux disorder (GERD) was identified.
Review of the physician's orders revealed the current use of famotidine (medication for treatment of GERD)
20 milligrams (mg) twice daily and protonix (medication for treatment of GERD) 20 mg daily.
Further review of the medical record including physician's progress notes and hospital records identified no
current or prior diagnosis of GERD or justification for the duplicate medication therapy.
Interview with the Director of Nursing on 06/24/25 at 2:35 P.M. verified Resident #46 did not have a
diagnosis of GERD and received duplicate medication therapy for GERD.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365496
If continuation sheet
Page 4 of 4